PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market ... DigitalJournal.com Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients ... |
